newsfilter
← Latest News
PR Newswire·

Immunic to Participate in Investor and Scientific Conferences in September

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic...